162 related articles for article (PubMed ID: 30413812)
1. Transplant-associated thrombotic microangiopathy: is the treatment more expensive than the disease?
Vaughn JL; Zhao Q; Epperla N; Puto M; Roddy J; Elder P; Blum W; Klisovic R; Jaglowski S; Penza S; William B; Andritsos L; Brammer JE; Hofmeister C; Efebera Y; Benson D; Devine S; Cataland S; Vasu S
Bone Marrow Transplant; 2019 Jun; 54(6):913-916. PubMed ID: 30413812
[No Abstract] [Full Text] [Related]
2. Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.
Khosla J; Yeh AC; Spitzer TR; Dey BR
Bone Marrow Transplant; 2018 Feb; 53(2):129-137. PubMed ID: 28967899
[TBL] [Abstract][Full Text] [Related]
3. The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy.
Balassa K; Andrikovics H; Remenyi P; Batai A; Bors A; Kiss KP; Szilvasi A; Rajczy K; Inotai D; Gopcsa L; Lengyel L; Barta A; Reti M; Tordai A; Masszi T
Bone Marrow Transplant; 2015 Oct; 50(10):1321-5. PubMed ID: 26146809
[TBL] [Abstract][Full Text] [Related]
4. Transplant-associated thrombotic microangiopathy.
Renaudon-Smith E; De La Fuente J; Bain BJ
Am J Hematol; 2016 Nov; 91(11):1160. PubMed ID: 27348509
[No Abstract] [Full Text] [Related]
5. Thrombotic microangiopathy with concomitant GI aGVHD after allogeneic hematopoietic stem cell transplantation: Risk factors and outcome.
Zhang XH; Liu X; Wang QM; He Y; Zhu XL; Zhang JM; Han W; Chen H; Chen YH; Wang FR; Wang JZ; Zhang YY; Mo XD; Chen Y; Wang Y; Fu HX; Chang YJ; Xu LP; Liu KY; Huang XJ
Eur J Haematol; 2018 Feb; 100(2):171-181. PubMed ID: 29114931
[TBL] [Abstract][Full Text] [Related]
6. Complement in Pathophysiology and Treatment of Transplant-Associated Thrombotic Microangiopathies.
Jodele S
Semin Hematol; 2018 Jul; 55(3):159-166. PubMed ID: 30032753
[TBL] [Abstract][Full Text] [Related]
7. Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning.
Willems E; Baron F; Seidel L; Frère P; Fillet G; Beguin Y
Bone Marrow Transplant; 2010 Apr; 45(4):689-93. PubMed ID: 19718063
[TBL] [Abstract][Full Text] [Related]
8. Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation.
Arai Y; Yamashita K; Mizugishi K; Watanabe T; Sakamoto S; Kitano T; Kondo T; Kawabata H; Kadowaki N; Takaori-Kondo A
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1683-9. PubMed ID: 24055655
[TBL] [Abstract][Full Text] [Related]
9. [Management of transplant-associated thrombotic microangiopathy].
Ikezoe T
Rinsho Ketsueki; 2018; 59(10):2307-2314. PubMed ID: 30305540
[TBL] [Abstract][Full Text] [Related]
10. Kidney Disease Following Hematopoietic Stem Cell Transplantation.
Abudayyeh A; Wanchoo R
Adv Chronic Kidney Dis; 2022 Mar; 29(2):103-115.e1. PubMed ID: 35817518
[TBL] [Abstract][Full Text] [Related]
11. Plasmapheresis-refractory thrombotic microangiopathy in a hematopoietic stem cell transplant recipient.
Vasko R; Groenewold F; Korsten P; Müller GA; Koziolek M
Ther Apher Dial; 2011 Oct; 15(5):507-9. PubMed ID: 21974708
[No Abstract] [Full Text] [Related]
12. Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy.
Dandoy CE; Davies SM; Hirsch R; Chima RS; Paff Z; Cash M; Ryan TD; Lane A; El-Bietar J; Myers KC; Jodele S
Biol Blood Marrow Transplant; 2015 Jan; 21(1):113-8. PubMed ID: 25300868
[TBL] [Abstract][Full Text] [Related]
13. Use of defibrotide to treat adult patients with transplant-associated thrombotic microangiopathy.
Martínez-Muñoz ME; Forés R; Lario A; Bautista G; Bueno JL; de Miguel C; Navarro B; De Laiglesia A; Sánchez-Guerrero A; Cabrera JR; Duarte RF
Bone Marrow Transplant; 2019 Jan; 54(1):142-145. PubMed ID: 29899573
[No Abstract] [Full Text] [Related]
14. High mortality in hematopoietic stem cell transplant-associated thrombotic microangiopathy with and without concomitant acute graft-versus-host disease.
Kraft S; Bollinger N; Bodenmann B; Heim D; Bucher C; Lengerke C; Kleber M; Tsakiris DA; Passweg J; Tzankov A; Medinger M
Bone Marrow Transplant; 2019 Apr; 54(4):540-548. PubMed ID: 30108323
[TBL] [Abstract][Full Text] [Related]
15. Management of thrombotic microangiopathy after hematopoietic cell transplantation: A position statement of ThREG (Turkish Hematology Research and Education Group).
Kaya AH; Tekgunduz E
Transfus Apher Sci; 2021 Dec; 60(6):103313. PubMed ID: 34785151
[TBL] [Abstract][Full Text] [Related]
16. Emerging Concepts in Hematopoietic Stem Cell Transplantation-Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments.
Wanchoo R; Bayer RL; Bassil C; Jhaveri KD
Am J Kidney Dis; 2018 Dec; 72(6):857-865. PubMed ID: 30146419
[TBL] [Abstract][Full Text] [Related]
17. Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation.
Postalcioglu M; Kim HT; Obut F; Yilmam OA; Yang J; Byun BC; Kupiec-Weglinski S; Soiffer R; Ritz J; Antin JH; Alyea E; Koreth J; Cutler C; Armand P; Paik JM; Leaf DE; Ho VT; Abdi R
Biol Blood Marrow Transplant; 2018 Nov; 24(11):2344-2353. PubMed ID: 29758394
[TBL] [Abstract][Full Text] [Related]
18. Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study.
Ye Y; Zheng W; Wang J; Hu Y; Luo Y; Tan Y; Shi J; Zhang M; Huang H
Hematol Oncol; 2017 Dec; 35(4):821-827. PubMed ID: 27245857
[TBL] [Abstract][Full Text] [Related]
19. Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.
Jodele S; Fukuda T; Mizuno K; Vinks AA; Laskin BL; Goebel J; Dixon BP; Chima RS; Hirsch R; Teusink A; Lazear D; Lane A; Myers KC; Dandoy CE; Davies SM
Biol Blood Marrow Transplant; 2016 Feb; 22(2):307-315. PubMed ID: 26456258
[TBL] [Abstract][Full Text] [Related]
20. Successful Treatment of Veno-occlusive Disease, Transplantation-Associated Thrombotic Microangiopathy, and Acute Graft-vs-Host Disease in a Patient with Relapsed Epstein-Barr Hemophagocytic Lymphohistiocytosis After Haploidentical Hematopoietic Stem Cell Transplantation: A Case Report.
Zhang C; Tan X; Yao H; Liu Y; Gao L; Gao L; Kong PY; Zhang X
Transplant Proc; 2019 Nov; 51(9):3159-3162. PubMed ID: 31711585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
